Comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 2p21 Microdeletion Syndrome Without Cystinuria and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome Without Cystinuria C4749458
A chromosomal deletion on chromosome 2 involving some genes shared with another condition but without the kidney component. Supportive care addresses each person's specific needs.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
2p21 Microdeletion Syndrome Without Cystinuria C4749458
0-null
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
2p21 Microdeletion Syndrome Without Cystinuria C4749458
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome Without Cystinuria C4749458
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome Without Cystinuria C4749458
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
2p21 Microdeletion Syndrome Without Cystinuria C4749458
congenital
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
2p21 Microdeletion Syndrome Without Cystinuria C4749458
rare-disease
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-without-cystinuria-C4749458 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Deletion involving 2p21, sharing some genes with a related condition. | Extra genetic material from 14q32. | High |
| Kidney or cystinuria component | Source specifically states no cystinuria or kidney component. | Kidney involvement is not established in the supplied description. | Moderate |
| Development and facial appearance | A specific developmental or facial pattern is not established here. | May include developmental effects, intellectual disability, and distinctive facial features. | Moderate |
When to favor each condition
Choose 2p21 Microdeletion Syndrome Without Cystinuria C4749458 when
A confirmed 2p21 deletion without cystinuria
The locus, deletion, and absent kidney component match this concept.
High
Separating it from related 2p21 deletion with cystinuria
Absence of cystinuria is the stated diagnostic boundary.
High
Planning care for a severe congenital chromosomal condition
The source rates it severe and emphasizes individualized supportive care.
Moderate
Choose 14q32 Duplication Syndrome C4225449 when
Confirmed extra material at 14q32
The diagnosis depends on a 14q32 duplication, not a 2p21 deletion.
High
Developmental disability with reported facial features and a 14q finding
These features are described for the duplication but not established for the deletion.
Moderate
Symptom-focused care for a moderate congenital disorder
The source describes moderate severity and management of individual symptoms.
Moderate
How key tests differ
| Test | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | Copy-number loss involving 2p21. | Copy-number gain involving 14q32. | Locus and direction of change distinguish them; laboratory and clinician confirmation is required. |
| Cystine or kidney evaluation | Cystinuria is absent by definition; other results are not established. | No characteristic kidney result is established. | An abnormal urine or kidney result is not itself a diagnosis of either syndrome. |
| Developmental assessment | Expected profile is not established in the source. | May show developmental delay or intellectual disability. | Assessment guides support but does not replace genetic confirmation. |
Prognosis comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458
- Outcome
- Long-term outcome is not established; it is described as severe and chronic.
- Factors
- Deletion content, associated findings, and access to supportive care.
14q32 Duplication Syndrome C4225449
- Outcome
- Outcome is not established; it is described as moderate with possible developmental effects.
- Factors
- Extent of duplicated material, developmental needs, and other health issues.
Time frame: Lifelong congenital course; survival and milestones are not established.
The individual genetic result and clinical findings should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Cystinuria-related kidney disease | Explicitly absent; other kidney complications are not established. Not established from the supplied description. Do not assume kidney disease in either condition. |
| Neurodevelopmental needs | Specific pattern is not established, although severity is listed as severe. Developmental effects and intellectual disability may occur. Needs vary and require individualized assessment. |
| Other health issues | Specific complications beyond supportive needs are not established. Other health issues may occur but are not itemized. Evaluation should follow clinical findings rather than a fixed complication list. |
Patient education highlights
- HighDifferent genetic findings
These conditions involve different chromosomal changes and are not contagious.
- HighSupportive care
Care addresses each person's needs; no standard dose or definitive treatment is established here.
- MediumUncertainty
Available descriptions are limited. Discuss unexpected findings with a genetics clinician.